Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population‐Based Cohort Study of 1.29 Million Young Men

Few data are available on whether changes in metabolic syndrome affect incident gout. This study was undertaken to assess associations between metabolic syndrome status and incident gout, as well as changes in the clinical characteristics of metabolic syndrome and incident gout, in a cohort of young men.

[1]  B. Cho,et al.  National General Health Screening Program in Korea: history, current status, and future direction: A scoping review , 2022, Precision and Future Medicine.

[2]  Seil Oh,et al.  Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population‐Based Study , 2021, Journal of the American Heart Association.

[3]  Shuohua Chen,et al.  Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study , 2021, Frontiers in Cardiovascular Medicine.

[4]  Jin-su Park,et al.  Clinical Study Using Healthcare Claims Database , 2021, Journal of rheumatic diseases.

[5]  Hyon K. Choi,et al.  Dietary and Lifestyle-Centered Approach in Gout Care and Prevention , 2021, Current Rheumatology Reports.

[6]  A. Vazquez,et al.  Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities , 2021, European Journal of Human Genetics.

[7]  H. Kwon,et al.  Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study , 2021, Scientific Reports.

[8]  D. Shin,et al.  Menopausal factors and risk of seropositive rheumatoid arthritis in postmenopausal women: a nationwide cohort study of 1.36 million women , 2020, Scientific Reports.

[9]  T. Merriman,et al.  Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study. , 2020, Joint bone spine.

[10]  R. Newson,et al.  Incident gout and weight change patterns: a retrospective cohort study of US adults , 2020, Arthritis Research & Therapy.

[11]  R. Wong,et al.  Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. , 2020, JAMA.

[12]  J. Singh,et al.  Gout epidemiology and comorbidities. , 2020, Seminars in arthritis and rheumatism.

[13]  Sundar Natarajan,et al.  The Influence of Metabolic Syndrome in Predicting Mortality Risk Among US Adults: Importance of Metabolic Syndrome Even in Adults With Normal Weight , 2020, Preventing chronic disease.

[14]  M. Hasan,et al.  Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults , 2020, Scientific Reports.

[15]  Kyungdo Han,et al.  Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study , 2020, Scientific Reports.

[16]  Kyungdo Han,et al.  Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status , 2019, Annals of Internal Medicine.

[17]  K. Niu,et al.  Global, regional and national burden of gout, 1990-2017: a systematic analysis of the Global Burden of Disease Study. , 2019, Rheumatology.

[18]  P. Zeng,et al.  Evaluation of the causal effects of blood lipid levels on gout with summary level GWAS data: two-sample Mendelian randomization and mediation analysis , 2019, Journal of Human Genetics.

[19]  Kyungdo Han,et al.  Women with Metabolic Syndrome and General Obesity Are at a Higher Risk for Significant Hyperuricemia Compared to Men , 2019, Journal of clinical medicine.

[20]  Zhimin Ma,et al.  Obesity-Related Genetic Variants and Hyperuricemia Risk in Chinese Men , 2019, Front. Endocrinol..

[21]  C. Mallen,et al.  Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies , 2018, Arthritis Research & Therapy.

[22]  J. Park,et al.  Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013) , 2018, PloS one.

[23]  S. Bouret,et al.  Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic. , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  M. Saklayen.  The Global Epidemic of the Metabolic Syndrome , 2018, Current Hypertension Reports.

[25]  Gabriel Coll-de-Tuero,et al.  The dynamic behaviour of metabolic syndrome and its components in an eight-year population-based cohort from the Mediterranean , 2017, PloS one.

[26]  R. Testa,et al.  The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications , 2017, Nutrients.

[27]  J. Myong,et al.  The current condition of the workers’ general health examination in South Korea: a retrospective study , 2017, Annals of Occupational and Environmental Medicine.

[28]  K. Langová,et al.  Correlation of uric acid levels and parameters of metabolic syndrome. , 2017, Physiological research.

[29]  Y. Lee,et al.  Metabolic syndrome: prevalence and risk factors in Korean gout patients , 2016, The Korean journal of internal medicine.

[30]  L. Jacobsson,et al.  Validity of gout diagnosis in Swedish primary and secondary care - a validation study , 2015, BMC Musculoskeletal Disorders.

[31]  W. Pan,et al.  Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: A prospective study , 2013, Arthritis care & research.

[32]  J. Coresh,et al.  Hypertension and the Risk of Incident Gout in a Population‐Based Study: The Atherosclerosis Risk in Communities Cohort , 2012, Journal of clinical hypertension.

[33]  I. Peláez-Ballestas,et al.  Diagnosis of Chronic Gout: Evaluating the American College of Rheumatology Proposal, European League Against Rheumatism Recommendations, and Clinical Judgment , 2010, The Journal of Rheumatology.

[34]  M. Jokela,et al.  Overall Diet History and Reversibility of the Metabolic Syndrome Over 5 Years , 2010, Diabetes Care.

[35]  C. van Weel,et al.  A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. , 2010, Archives of internal medicine.

[36]  M. Rodríguez-Moran,et al.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[37]  Dongmei Meng,et al.  Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions , 2009, Inflammation Research.

[38]  M. Rodríguez-Moran,et al.  The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. , 2008, Metabolic syndrome and related disorders.

[39]  K. Choi,et al.  The Prevalence of Metabolic Syndrome in Patients with Gout: A Multicenter Study , 2005, Journal of Korean medical science.

[40]  N. Kamatani,et al.  Trends in the manifestations of gout in Taiwan. , 2003, Rheumatology.

[41]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[42]  R. Weisell,et al.  Body mass index as an indicator of obesity , 2002 .

[43]  D. Mccarty,et al.  Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.

[44]  Seong-Kyu Kim.  Interrelationship of Uric Acid, Gout, and Metabolic Syndrome: Focus on Hypertension, Cardiovascular Disease, and Insulin Resistance , 2018 .

[45]  E. Guallar,et al.  Korean National Health Insurance Database. , 2016, JAMA internal medicine.